2002
DOI: 10.1016/s0008-6363(02)00283-3
|View full text |Cite
|
Sign up to set email alerts
|

Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFα gene

Abstract: We demonstrate that cardiac TNFalpha production is required for ischemic preconditioning-induced cardioprotection but not necessary in pharmacologic preconditioning with adenosine or diazoxide in TNFalpha-/- mice. Moreover, TNFalpha administration is sufficient to activate preconditioning in wild-type mice. Finally, as 5-hydroxydecanoate abrogates ischemic, adenosine and TNFalpha induced preconditioning, this suggests that diverse signaling pathways converge at the level of mitochondrial K(ATP) channel activat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
80
1
3

Year Published

2003
2003
2011
2011

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(86 citation statements)
references
References 42 publications
2
80
1
3
Order By: Relevance
“…Although it is known that TNF-␣ acts through at least two different receptors [TNF-␣ receptor 1 and 2 (TNFR1 and TNFR2)], it is not clear which receptor(s) mediates the effects of TNF-␣ in the post-MI tissue processes of cardiac remodeling. Indeed, the effects of blocking TNF-␣ in MI remain controversial; production of MI in mice lacking expression of both TNFR1 and TNFR2 led to increased infarct sizes and myocardial apoptosis in the early post-MI period (17), whereas pre-MI neutralization (22,34) reduces infarct size. Furthermore, the reduction of ischemic injury achieved by late ischemia-reperfusion is dependent on TNF-␣ (41), whereas the role of TNF-␣ in the classical (early) preconditioning reduction of MI size remains unclear (4).…”
mentioning
confidence: 99%
“…Although it is known that TNF-␣ acts through at least two different receptors [TNF-␣ receptor 1 and 2 (TNFR1 and TNFR2)], it is not clear which receptor(s) mediates the effects of TNF-␣ in the post-MI tissue processes of cardiac remodeling. Indeed, the effects of blocking TNF-␣ in MI remain controversial; production of MI in mice lacking expression of both TNFR1 and TNFR2 led to increased infarct sizes and myocardial apoptosis in the early post-MI period (17), whereas pre-MI neutralization (22,34) reduces infarct size. Furthermore, the reduction of ischemic injury achieved by late ischemia-reperfusion is dependent on TNF-␣ (41), whereas the role of TNF-␣ in the classical (early) preconditioning reduction of MI size remains unclear (4).…”
mentioning
confidence: 99%
“…On the other hand, inflammatory cytokines such as TNF-␣ are also involved in triggering IP, because pretreatment with TNF-␣ antibodies abolished infarct size reduction achieved by late IP in a rat model of myocardial infarction (22), and genetic ablation of TNF-␣ abolishes infarct size reduction by classic IP in mice (19).…”
mentioning
confidence: 99%
“…TNF-α has been implicated in the development of ischemic tolerance, since this effect is not observed in TNF-α knockout mice (27). Likewise, in one study, TNF-α protected cultured neurons against ischemic death and cultured astrocytes against the proinflammatory effects of TNF-α (28).…”
Section: Discussionmentioning
confidence: 99%
“…These would reduce NO synthase induction in the inflamed bladder and the consequent increase in NO production. In addition, rIPC possibly inhibits IFO-induced inducible NO synthase by producing small amounts of NO and/or TNF-α during the reperfusion phase of IPC, especially since production of these substances has been implicated in the development of ischemic tolerance after induction of IPC (27,28,30).…”
Section: Discussionmentioning
confidence: 99%